FOLH1 and prostate cancer: Therefore, it was found in a prospective study that combination of PSMA PET and multiparametric MRI provided a reliable TNM staging in patients with prostate cancer with a change in the therapeutic management for almost one third of the patients (75), PSMA PET being particularly interesting to delineate lymph node metastases (76).